Covid-19 Antigen Test & Medicine

Wholesaler of a wide range of products which include molnupiravir 200mg capsule, mylab antigen test kits, covifor 100 mg injection and remdesvir redyx 100mg injection.

Molnupiravir 200mg Capsule

REQUEST CALLBACK

Get Best Quote

Approx. Rs 1,650 / BottleGet Latest Price

Product Details:

Minimum Order Quantity	1 Bottle
Packaging Size	Bottle
Strength	200Mg
Composition	molnupiravir
Treatment	covid 19 treatment
Prescription/Non prescription	Prescription
Brand	molnunat 200
Manufacturer	natco ltd

Molnupiravir, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2. Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral action through introduction of copying errors during viral RNA replication.

Yes! I am interested

Mylab Antigen Test Kits

REQUEST CALLBACK

Get Best Quote

Approx. Rs 120 / UnitGet Latest Price

Product Details:

Minimum Order Quantity	10 Unit
Number of Reactions(Preps)/Kit	1
Number of Reactions	1
Brand	coviself test kit
ICMR Approved	Yes
Test Method	Antigen Test
Result Time (Rapid Kits)	20 minutes
Sample Type	Nasal Swab

Is COVID-19 rapid antigen test accurate? Rapid antigen tests are highly specific, which means that they generate relatively few false positives. However, a positive result is more likely to be a false positive when the prevalence of the virus is low; in these instances, people may want to take a second test.

Yes! I am interested

Covifor 100 Mg Injection

REQUEST CALLBACK

Get Best Quote

Approx. Rs 1,400 / VialGet Latest Price

Product Details:

Minimum Order Quantity	5 Vial
Packaging Size	20 ml
Strength	100 Mg
Composition	Remdesivir Inj
Treatment	To treat coronavirus infection
Prescription/Non prescription	Prescription
Form	Injection
Brand	Covifor Injection
Manufacturer	Mylan
Shelf life	1 Year

Remdesivir (Covifor) was the first drug approved by the FDA for treating the SARS-CoV-2 virus. It is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older who weigh at least 40 kg. The broad-spectrum antiviral is a nucleotide analog prodrug.Full approval was preceded by the US FDA issuing an EUA (emergency use authorization) on May 1, 2020 to allow prescribing remdesivir for severe COVID-19 (confirmed or suspected) in hospitalized adults and children.Upon approval of remdesivir in adults and adolescents, the EUA was updated to maintain the ability for prescribers to treat pediatric patients weighing 3.5 kg to less than 40 kg or children younger than 12 years who weigh at least 3.5 kg.

Remdesivir is given by injection into a vein usually once daily for 5 to 10 days. It is infused over a period ranging from 30 minutes to 2 hours.

The length of treatment depends on your medical condition, response to treatment, and the study guidelines.

An infusion reaction may occur with remdesivir with symptoms such as low or high blood pressure, dizziness, slow/fast heartbeat, fever, nausea, vomiting, sweating, and shivering. A slower rate of infusion may help to lessen the risk of this reaction. The healthcare professional should monitor for side effects during remdesivir treatment.

Information is limited and it is unknown at this time if remdesivir causes serious side effects.

In the case of a serious allergic reaction, symptoms may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.

Yes! I am interested

Remdesvir Redyx 100Mg Injection

REQUEST CALLBACK

Get Best Quote

Approx. Rs 1,400 / VialGet Latest Price

Product Details:

Minimum Order Quantity	5 Vial
Packaging Size	20 Ml
Brand	Redyx L
Manufacturer	Dr.Reddys
Composition	Remedisivir
Treatment	For SARS-CoV-2 virus
Prescription/Non prescription	Prescription
Form	Injection
Shelf life	1Year
Country of Origin	Made in India

Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg). Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.
Remdesivir injection may cause serious reactions during and after the infusion of the medication. A doctor or nurse will monitor you carefully while you are receiving the medication. Tell your doctor or nurse immediately if you experience any of the following symptoms during or after the infusion: chills or shivering; nausea; vomiting; sweating; dizziness upon standing up; rash; wheezing or shortness of breath; abnormally fast or slow heartbeat; or swelling of the face, throat, tongue, lips, or eyes. Your doctor may need to slow down your infusion or stop your treatment if you experience these side effects.
The FDA has approved an Emergency Use Authorization (EUA) to allow children weighing 8 pounds (3.5 kg) to less than 88 pounds (40 kg) or children less than 12 years of age weighing at least 8 pounds (3.5 kg) who are hospitalized with severe COVID-19 to receive remdesivir.

Remdesivir may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

nausea
pain, bleeding, bruising of the skin, soreness, or swelling near the place where the medication was injected

Some side effects can be serious. If you experience any of these symptoms or those in the HOW section, call your doctor immediately or get emergency medical treatment: